Iter-4360dd15-0068-transcript
第 68 轮执行轨迹
→ call search_memory({"limit":8,"query":"4360dd15 33977284 29408453 abstract endpoint aging criteria"}) → call list_recent({"n":8})
→ call list_by_tag({"limit":10,"tag":"4360dd15"})
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0060-transcript", "tags": "iteration transcript", "modified": "20260424200117000", "preview": "!! 第 60 轮执行轨迹
→ call search_memory({\"limit\":10,\"query\":\"4360dd15 NEXT_FOCUS 剩余 10 条候选 PMID 研究类型 保留 排除 理由 extension follow-up secondary analysis\"}) → call list_recent({\"n\":10}) → call list_tools({}) 【tool:search_memory】 {\"ok\": true, \"results\": [{\"title\": \"Iter-4360dd15-0059-transcript\", \"tags\": \"iteration transcript\", \"modified\": \"20260424195947000\", \"preview\": \"!! 第 59 轮执行轨迹 →"}, {"title": "Iter-4360dd15-0010-transcript", "tags": "iteration transcript", "modified": "20260424175830000", "preview": "!! 第 10 轮执行轨迹 → call search_memory({\"limit\":8,\"query\":\"4360dd15 rapamycin review 2024 trial endpoint remaining 11\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) 【tool:search_memory】 {\"ok\": true, \"results\": [{\"title\": \"Iter-4360dd15-0007-transcript\", \"tags\": \"iteration transcript\", \"modified\": \"20260424174944000\", \"preview\": \"!! 第 7 轮执行轨迹 → cal"}, {"title": "Iter-4360dd15-0037-transcript", "tags": "iteration transcript", "modified": "20260424191347000", "preview": "!! 第 37 轮执行轨迹 → call search_memory({\"limit\":8,\"query\":\"4360dd15 PMID 38310895 reference chain Crossref 75 references human trial rapamycin everolimus sirolimus\"}) → call list_recent({\"n\":8}) → call list_tools({}) 【tool:search【tool:list_recent】
{"ok": true, "items": [{"title": "Iter-4360dd15-0067-reflection", "modified": "20260424201155000", "tags": "iteration reflection"}, {"title": "NEXT_FOCUS", "modified": "20260424201155000", "tags": "pinned focus"}, {"title": "优先用可访问全文源替代出版社页", "modified": "20260424201155000", "tags": "lesson pubmed-verification europe-pmc abstract-extraction"}, {"title": "Iter-4360dd15-0067-transcript", "modified": "20260424201146000", "tags": "iteration transcript"}, {"title": "Iter-4360dd15-0067-abstract-endpoints-aging-criteria", "modified": "20260424201141000", "tags": "4360dd15 knowledge fact method stratification"}, {"title": "Iter-4360dd15-0066-reflection", "modified": "20260424200940000", "tags": "iteration reflection"}, {"title": "绕开 PubMed HTML,优先用 PMC/Europe PMC 抽摘要", "modified": "20260424200940000", "tags": "lesson pubmed-verification europe-pmc abstract-extraction"}, {"title": "Iter-4360dd15-0066-transcript", "modified": "20260424200932000", "tags": "iteration transcript"}]}
【tool:list_by_tag】
{"ok": true, "items": [{"title": "Iter-4360dd15-0067-abstract-endpoints-aging-criteria", "modified": "20260424201141000"}, {"title": "Iter-4360dd15-0066-TierA-abstracts-and-endpoints-for-aging-criteria", "modified": "20260424200925000"}, {"title": "Iter-4360dd15-0065-minimal-relevance-decision-rules-for-retained-mtor-trials", "modified": "20260424200748000"}, {"title": "Iter-4360dd15-0064-relevance-tiering-10-pmids", "modified": "20260424200602000"}, {"title": "Iter-4360dd15-0063-10-pmid-audit-table", "modified": "20260424200432000"}, {"title": "Iter-4360dd15-0062-pubmed-title-verification-10-pmids", "modified": "20260424200328000"}, {"title": "Iter-4360dd15-0061-candidate-audit-10-remaining-pmids", "modified": "20260424200221000"}, {"title": "PMID 38310895 is a review, not a primary trial", "modified": "20260424200109000"}, {"title": "PMID 35040506 longitudinal analysis is embedded in primary trial", "modified": "20260424195939000"}, {"title": "Iter-4360dd15-0058-longevity-evidence-proximity-tagging", "modified": "20260424195827000"}]}
→ call pubmed_search({"limit":3,"query":"33977284"})
→ call pubmed_search({"limit":3,"query":"29408453"})
【tool:pubmed_search】
{"ok": true, "query": "33977284", "results": [{"pmid": "33977284", "title": "Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.", "source": "Lancet Healthy Longev", "pubdate": "2021 May", "authors": ["Mannick JB", "Teo G", "Bernardo P", "Quinn D", "Russell K", "Klickstein L", "Marshall W", "Shergill S"], "url": "https://pubmed.ncbi.nlm.nih.gov/33977284/"}]}
【tool:pubmed_search】
{"ok": true, "query": "29408453", "results": [{"pmid": "29408453", "title": "A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.", "source": "Exp Gerontol", "pubdate": "2018 May", "authors": ["Kraig E", "Linehan LA", "Liang H", "Romo TQ", "Liu Q", "Wu Y", "Benavides AD", "Curiel TJ"], "url": "https://pubmed.ncbi.nlm.nih.gov/29408453/"}]}
→ call read_note({"title":"Iter-4360dd15-0067-abstract-endpoints-aging-criteria"})
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0067-abstract-endpoints-aging-criteria", "tags": "4360dd15 knowledge fact method stratification", "text": "!! 第 67 轮:从两篇 Tier A 试验抽取主要终点与最直接的衰老判据\n\n本轮目标:只从 PMID 33977284 与 PMID 29408453 的可访问摘要中,提取“主要终点”与“最直接的衰老相关判据”,作为后续审计/分层的可复用规则。\n\n!! PMID 33977284\n'''题名''':Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.\n\n'''可访问摘要中的主要终点'''\n- phase 2b:16 周冬季感冒/流感季期间的 laboratory-confirmed RTIs 发生率;摘要中指出在第二个预设分析里,RTB101 10 mg 每日一次降低了至少一次 laboratory-confirmed RTI 的比例。\n- phase 3:clinically symptomatic respiratory illness 的发生率(不要求实验室确认)。\n\n'''最直接的衰老相关判据'''\n- 研究对象:至少 65 岁的 older adults。\n- 生物学判据:IFN-induced antiviral gene expression 上调。\n- 结果层面的 aging proxy:RTI 易感性/感染负担是否下降。\n- 该文并未把寿命或功能衰退作为终点,而是把“老年免疫衰老”映射到抗病毒反应与呼吸道感染结局。\n\n'''Europe PMC / core 元数据证据'''\n- PMID: 33977284\n- PMCID: PMC8102040\n- DOI: 10.1016/S2666-7568(21)00062-3\n- abstractText 明确给出 phase 2b 与 phase 3 的 primary outcome。\n\n!! PMID 29408453\n'''题名''':A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.\n\n'''可访问摘要中的主要终点/监测重点'''\n- 安全性/耐受性:feasibility and safety。\n- 代谢安全性:CBC、CMP、HbA1c、OGTT。\n- 认知:EXIT25、SLUMS、TAPS。\n- 体能:handgrip strength、40-foot timed walks。\n- 免疫衰老:serum pro-inflammatory cytokines、blood cell subsets。\n\n'''最直接的衰老相关判据'''\n- 研究对象:70–95 岁 healthy older
→ call define_tool({"name":"europmc_endpoint_extractor","description":"Fetch Europe PMC metadata/abstract for a PMID and extract sentences that look like primary outcomes or direct aging-related criteria. Reusable for rapid abstract auditing.","code":"import re, json\nfrom urllib.parse import quote\nfrom urllib.request import urlopen, Request\n\nSENT_SPLIT = re.compile(r'(?<=[.!?])\\s+(?=[A-Z\\[])')\nPRIMARY_PATTERN)
【tool:define_tool】
{"ok": false, "error": "参数错误: tool_define_tool() missing 1 required positional argument: 'parameters'"}
→ call define_tool({"name":"europmc_endpoint_extractor","description":"Fetch Europe PMC metadata/abstract for a PMID and extract sentences that look like primary outcomes or direct aging-related criteria. Reusable for rapid abstract auditing.","code":"import re, json\nfrom urllib.parse import quote\nfrom urllib.request import urlopen, Request\n\nSENT_SPLIT = re.compile(r'(?<=[.!?])\\s+(?=[A-Z\\[])')\nPRIMARY_PATTERN)
【tool:define_tool】
{"ok": false, "error": "参数错误: tool_define_tool() missing 1 required positional argument: 'parameters'"}
→ call list_tools({})
【tool:list_tools】
{"ok": true, "tools": [{"name": "search_memory", "description": "在 TiddlyWiki 长期记忆中按关键字搜索(支持中文空格分隔),返回标题、标签、预览。每轮迭代开始前应先调用以回忆。", "custom": false}, {"name": "read_note", "description": "读取某一条 tiddler 的完整正文。", "custom": false}, {"name": "write_note", "description": "向 TiddlyWiki 写入(或覆盖)一条 tiddler。这是 Sisyphus 的长期记忆入口——每轮至少写一条。建议标签:knowledge, experiment, reflection, plan, idea, fact, question, lesson。TiddlyWiki 标记:!! 小标题,''粗体'',斜体,其它tiddler。", "custom": false}, {"name": "list_recent", "description": "列出最近修改过的 tiddler。", "custom": false}, {"name": "list_by_tag", "description": "按标签列出相关 tiddler。", "custom": false}, {"name": "run_python", "description": "在 workspace/ 下以子进程执行一段 Python 代码,返回 stdout/stderr。用于计算、模拟、验证假设、抓取公开数据(禁止任何破坏性操作)。", "custom": false}, {"name": "read_file", "description": "读取 workspace/ 下的某个文件。", "custom": false}, {"name": "write_file", "description": "向 workspace/ 下写入文件(默认覆盖,append=true 时追加)。", "custom": false}, {"name": "list_files", "description": "列出 workspace/ 下的文件。", "custom": false}, {"name": "web_fetch", "description": "抓取任意公开 URL(GET),返回剥离 HTML 后的纯文本。适合读论文摘要、文档、博客、百科。", "custom": false}, {"name": "web_search", "description": "用 DuckDuckGo 搜索互联网,返回 title/url/snippet 列表。找入口、找链接、调研时用。", "custom": false}, {"name": "wiki_search", "description": "维基百科搜索:返回若干条目的摘要和 URL。lang 默认 en,可传 zh 等。", "custom": false}, {"name": "arxiv_search", "description": "arXiv 论文检索:标题/作者/摘要/链接。理论、数学、物理、CS、bio 类前沿论文的主入口。", "custom": false}, {"name": "pubmed_search", "descriptio
→ call define_tool({"name":"europmc_endpoint_extractor","description":"Fetch Europe PMC metadata/abstract for a PMID and extract sentences that look like primary outcomes or direct aging-related criteria. Reusable for rapid abstract auditing.","code":"import re, json\nfrom urllib.parse import quote\nfrom urllib.request import urlopen, Request\n\nSENT_SPLIT = re.compile(r'(?<=[.!?])\\s+(?=[A-Z\\[])')\nPRIMARY_PATTERN)
【tool:define_tool】
{"ok": false, "error": "参数错误: tool_define_tool() missing 1 required positional argument: 'parameters'"}
→ call define_tool({"parameters":{"name":"europmc_endpoint_extractor","description":"Fetch Europe PMC metadata/abstract for a PMID and extract sentences that look like primary outcomes or direct aging-related criteria. Reusable for rapid abstract auditing.","code":"import re, json\nfrom urllib.parse import quote\nfrom urllib.request import urlopen, Request\n\nSENT_SPLIT = re.compile(r'(?<=[.!?])\\s+(?=[A-Z\\[])')\nP)
【tool:define_tool】
{"ok": false, "error": "参数错误: tool_define_tool() missing 3 required positional arguments: 'name', 'description', and 'code'"}
→ call run_python({"code":"import json, re\nfrom urllib.request import urlopen, Request\nfrom urllib.parse import quote\n\npmids = ['33977284', '29408453']\n\ndef fetch(pmid):\n url = f'https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:{quote(pmid)}%20AND%20SRC:MED&format=json&pageSize=1'\n req = Request(url, headers={'User-Agent':'Mozilla/5.0'})\n with urlopen(req, timeout=30) as r:\n )
【tool:run_python】
{"ok": true, "stdout": "PMID 33977284\nTITLE Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.\nPMCID PMC8102040\nDOI 10.1016/s2666-7568(21)00062-3\nPRIMARY\nAGING\n---\nPMID 29408453\nTITLE A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.\nPMCID PMC5869166\nDOI 10.1016/j.exger.2017.12.026\nPRIMARY\nAGING\n---\n", "stderr": "", "returncode": 0}
→ call web_fetch({"max_chars":5000,"url":"https://europepmc.org/article/MED/33977284"})
→ call web_fetch({"max_chars":5000,"url":"https://europepmc.org/article/MED/29408453"})
【tool:web_fetch】
{"ok": true, "url": "https://europepmc.org/article/MED/33977284", "status": 200, "content_type": "text/html;charset=UTF-8", "text": "Europe PMC Europe PMC 1 Sign in | Create an account https://orcid.org https://plus.europepmc.org Europe PMC Menu About About Europe PMC Preprints in Europe PMC Funders Become a funder Governance Roadmap Outreach Tools Tools overview Article status monitor Grant finder External links service RSS feeds About SciLite annotations Annotations submission service Developers Developer resources Articles RESTful API Grants RESTful API API case studies SOAP web service Annotations API OAI service Bulk downloads Developers Forum Support User guide Search syntax guide Contact us Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus NOTICE: The ORCID Claiming tool has been temporarily disabled, because of technical issues. Please check back in later.", "truncated": false}
【tool:web_fetch】
{"ok": true, "url": "https://europepmc.org/article/MED/29408453", "status": 200, "content_type": "text/html;charset=UTF-8", "text": "Europe PMC Europe PMC 1 Sign in | Create an account https://orcid.org https://plus.europepmc.org Europe PMC Menu About About Europe PMC Preprints in Europe PMC Funders Become a funder Governance Roadmap Outreach Tools Tools overview Article status monitor Grant finder External links service RSS feeds About SciLite annotations Annotations submission service Developers Developer resources Articles RESTful API Grants RESTful API API case studies SOAP web service Annotations API OAI service Bulk downloads Developers Forum Support User guide Search syntax guide Contact us Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus NOTICE: The ORCID Claiming tool has been temporarily disabled, because of technical issues. Please check back in later.", "truncated": false}
→ call run_python({"code":"import json\nfrom urllib.request import urlopen, Request\nfrom urllib.parse import quote\n\nfor pmid in ['33977284','29408453']:\n url = f'https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:{quote(pmid)}%20AND%20SRC:MED&format=json&pageSize=1'\n req = Request(url, headers={'User-Agent':'Mozilla/5.0'})\n with urlopen(req, timeout=30) as r:\n data = json.lo)
【tool:run_python】
{"ok": true, "stdout": "PMID 33977284\nkeys ['id', 'source', 'pmid', 'pmcid', 'fullTextIdList', 'doi', 'title', 'authorString', 'journalTitle', 'issue', 'journalVolume', 'pubYear', 'journalIssn', 'pageInfo', 'pubType', 'isOpenAccess', 'inEPMC', 'inPMC', 'hasPDF', 'hasBook', 'hasSuppl', 'citedByCount', 'hasReferences', 'hasTextMinedTerms', 'hasDbCrossReferences', 'hasLabsLinks', 'hasTMAccessionNumbers', 'tmAccessionTypeList', 'firstIndexDate', 'firstPublicationDate']\nabstractText repr: None\n---\nPMID 29408453\nkeys ['id', 'source', 'pmid', 'pmcid', 'fullTextIdList', 'doi', 'title', 'authorString', 'journalTitle', 'journalVolume', 'pubYear', 'journalIssn', 'pageInfo', 'pubType', 'isOpenAccess', 'inEPMC', 'inPMC', 'hasPDF', 'hasBook', 'hasSuppl', 'citedByCount', 'hasReferences', 'hasTextMinedTerms', 'hasDbCrossReferences', 'hasLabsLinks', 'hasTMAccessionNumbers', 'tmAccessionTypeList', 'firstIndexDate', 'firstPublicationDate']\nabstractText repr: None\n---\n", "stderr": "", "returncode": 0}
→ call web_fetch({"max_chars":12000,"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8102040/"})
→ call web_fetch({"max_chars":12000,"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5869166/"})
【tool:web_fetch】
{"ok": true, "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8102040/", "status": 200, "content_type": "text/html; charset=utf-8", "text": "Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials - PMC Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock Locked padlock icon ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Search Log in Dashboard Publications Account settings Log out Search… Search NCBI Primary site navigation Search Logged in as: Dashboard Publications Account settings Log in Search PMC Full-Text Archive Search in PMC Journal List User Guide PERMALINK Copy As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Lancet Healthy Longev . 2021 May 6;2(5):e250–e262. doi: 10.1016/S2666-7568(21)00062-3 Search in PMC Search in PubMed View in NLM Catalog Add to search Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials Joan B Man
【tool:web_fetch】
{"ok": true, "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5869166/", "status": 200, "content_type": "text/html; charset=utf-8", "text": "A Randomized Control Trial to Establish the Feasibility and Safety of Rapamycin Treatment in an Older Human Cohort: Immunological, Physical Performance, and Cognitive Effects - PMC Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock Locked padlock icon ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Search Log in Dashboard Publications Account settings Log out Search… Search NCBI Primary site navigation Search Logged in as: Dashboard Publications Account settings Log in Search PMC Full-Text Archive Search in PMC Journal List User Guide PERMALINK Copy As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Exp Gerontol . Author manuscript; available in PMC: 2019 May 1. Published in final edited form as: Exp Gerontol. 2018 Feb 3;105:53–69. doi: 10.1016/j.exger.2017.12.026 Search in PMC Search in PubMed View in NLM Catalog Add to search A Randomized Control Tria
→ call write_note({"tags":["4360dd15","knowledge","fact","method"],"text":"!! 第 68 轮:从 PMC 可访问全文抽取两篇试验的 primary outcome 与直接衰老判据\n\n本轮子任务:只做一件事——把 PMID 33977284 与 PMID 29408453 的 primary outcome 和最直接的衰老相关判据从可访问全文中定位出来,作为后续审计的可复用证据。\n\n!! PMID 33977284\n'''题名''':Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials\n\n'''可验证的 primar)
【tool:write_note】
{"ok": true, "path": "C:\\Users\\yh599\\Documents\\GitHub\\LLM-yh\\Sisyphus\\wiki\\tiddlers\\Iter-4360dd15-0068-abstract-endpoint-extraction.tid", "title": "Iter-4360dd15-0068-abstract-endpoint-extraction"}
【assistant】
本轮已完成最小可验证子任务:从两篇 PMC 可访问全文中,锁定了各自的 primary outcome / primary endpoint,并把最直接的衰老相关判据压缩成可审计表述,已沉淀到记忆库。
要点:
- PMID 33977284
- primary outcome:phase 2b 为 16 周内 laboratory-confirmed RTIs 发生率;phase 3 为 clinically symptomatic respiratory illness 发生率。
- 衰老相关判据:≥65 岁 older adults;IFN-induced antiviral gene expression;RTI 易感性/感染负担作为 immune-aging proxy。
- PMID 29408453
- 研究主线:feasibility and safety。
- 衰老相关判据:70–95 岁 older adults;认知、体能、炎症因子、血细胞亚群、OGTT 等 aging proxy / safety proxy。
已写入:
- Iter-4360dd15-0068-abstract-endpoint-extraction
本轮额外发现:
- Europe PMC 的 abstractText 对这两条记录在 JSON 检索里为空,因此最稳妥路径是直接用 PMC 页面全文首段抽取摘要句,而不是依赖 Europe PMC JSON。
- 之前尝试把这条抽取流程封装成工具时,当前工具接口调用参数形式不匹配,未成功注册;但这不影响本轮证据抽取结果。
<NEXT_FOCUS>下一轮最值得深入的最窄子问题:把这两篇试验的“纳入人群限制/排除标准”抽成一套可复用的分层规则,判断它们的 aging proxy 证据能否外推到一般 older adults。</NEXT_FOCUS>
```